NCT06381154 2026-01-30
Photoradiation With Verteporfin to Facilitate Immunologic Activity of Pembrolizumab in Unresectable, Locally Advanced or Metastatic Pancreatic Cancer
Mayo Clinic
Phase 2 Recruiting
Clinical Trials
6 trialsNCT06306638 2025-11-25
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
Roswell Park Cancer Institute
Phase 1/2 Recruiting
NCT03033225 2025-07-30
Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study
Mayo Clinic
Phase 2 Completed
NCT04590664 2025-02-25
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
Emory University
Phase 1/2 Recruiting
NCT02702700 2019-03-20
PDT-lipo
Centre Hospitalier Universitaire Vaudois
Phase 1 Terminated
NCT02872064 2018-04-06
Treatment of Primary Breast Cancer Using PDT
University College, London
Phase NA Completed